⌘K

Login Start Free

Home/Filings/4/0001493152-24-004764

4//SEC Filing

Reveles Xavier Trinidad 4

Accession 0001493152-24-004764

CIK 0001712762other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:22 PM ET

Size

4.9 KB

Accession

0001493152-24-004764

Insider Transaction Report

Form 4

Period: 2024-01-31

bioAffinity Technologies, Inc.BIAF

Reveles Xavier Trinidad

Chief Operating Officer

Transactions

Award
Common Stock
2024-01-31+16,720→ 20,339 total

Footnotes (1)

[F1]Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024.

Documents

1 file

4
ownership.xmlPrimary

Issuer

bioAffinity Technologies, Inc.

CIK 0001712762

Entity typeother

Related Parties

1

filerCIK 0001993507

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 4:22 PM ET
Size: 4.9 KB

View on SEC.gov